Requiring drug manufacturers “to sell to contract pharmacies at the 340B discount is price-fixing,” an influential source of model bills for conservative state lawmakers says in a new post on its website.
“Legislators understandably worry about the cost of prescription drugs and making sure their constituents have access to the medicines they need,” writes Brooklyn Roberts, senior director of the American Legislative Exchange Council health and human services task force, in a Feb. 28 article on ALEC’s site. “However, fixing the price of drugs is not the way to accomplish that goal.”
Requiring drug manufacturers “to sell to contract pharmacies at the 340B discount is price-fixing,” an influential source of model bills for conservative state lawmakers says in a new post on its website.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
